Quantity | = | Concentration | x | Volume | x | Molecular Weight |
---|---|---|---|---|---|---|
= | x | x |
1) Click the Molarity Calculation Cart® button.
2) Specify the Concentration and Volume of your desired Molarity.
3) Click Calculate.
4) Your desired Quantity will be calculated and will be put under Quantity: (only for mg)
5) Click Add to Cart and then Proceed to checkout to complete the order. You will receive the quantity as you ordered as solvent-free form.
Alert: If you want to make a solution with a solvent (such DMSO), please add instructions in the notes section (such as 10 nM/1 mL in DMSO) and we will pack and deliver the product as a solution (such as 10 nM solution in 1 mL DMSO). If the product cannot be dissolved in DMSO or you would like to specify your own preferred solvent, please add detailed instructions in the notes section. All solutions must be shipped with an ice bag, costing an additional fee of $20 for S&H.
AOB6827
CAS: 241127-58-2
Chemical Name: NSC-680410; 1-Adamantyl 4-((2,5-dihydroxybenzyl)amino)benzoate
Warning: Last items in stock!
Availability date:
Quantity (mg or Unit) | Unit Price ($/mg or $/Unit) | Final Price |
---|---|---|
100 | $4.95 | Total: $495.00 |
50 | $5.72 | Total: $286.00 |
25 | $6.71 | Total: $167.75 |
10 | $7.92 | Total: $79.20 |
5 | $9.35 | Total: $46.75 |
Molecular Formula | C24H27NO4 |
Molecular Weight | 393.48 |
CAS Numbers | 241127-58-2 |
Storage Condition | 0°C (short term), -20°C (long term), desiccated |
Solubility | DMSO |
Purity | 98% by HPLC |
IUPAC/Chemical Name | 4-[[(2,5-Dihydroxyphenyl)methyl]amino]benzoic acid tricyclo[3.3.1.13,7]dec-1-yl ester |
InChl Key | YJZSUCFGHXQWDM-UHFFFAOYSA-N |
InChl Code | InChI=1S/C24H27NO4/c26-21-5-6-22(27)19(10-21)14-25-20-3-1-18(2-4-20)23(28)29-24-11-15-7-16(12-24)9-17(8-15)13-24/h1-6,10,15-17,25-27H,7-9,11-14H2 |
SMILES Code | O=C(C4=CC=C(NCC5=C(O)C=CC(O)=C5)C=C4)OC12CC(C3)CC(CC3C2)C1 |
References | 1) Svingen et al (2000) Effects of the bcl/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro. Clin.Cancer Res. 6 237 PMID: 10656455 2) Avramis et al (2002) In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines. Cancer Chemother.Pharmacol. 50 479 PMID: 12451475 3) Mow et al (2002) Effects of bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro. Blood 99 664 PMID: 11781252 |
Novel VISTA (V-domain immunoglobulin suppressor of T-cell activation) agonist
Novel activator of Fas-mediated death pathway in Bcr/Abl-positive leukaemia